Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...
Sam Altman-backed Retro Biosciences is raising $1 billion to develop drugs that extend human lifespan by 10 years, the FT ...
Sam Altman, the CEO of OpenAI, has announced a shift in his previously critical perspective on President Donald Trump.
Retro Biosciences Inc., a startup using artificial intelligence to discover new drugs, is reportedly raising $1 billion in ...
OpenAI CEO Sam Altman took the technology world by surprise on Thursday with the release of Operator, his company's first AI ...
Sam Altman's comments came amid a flurry of online exchanges between himself, Musk, and Microsoft over the $500 billion ...
Brazil's data protection watchdog has banned Tools for Humanity from offering payment for iris scanning in the country.
WIth one foot out the White House door, the Biden administration issued 2 documents Musk is now using in his battle to break ...